Posts tagged Value Pickr
KPI Green- Turning Sunshine Into Cashflows (22-11-2024)
Hope no issues in tenders they have won… through competitive bidding…
Jupiter Wagons Ltd (previously CEBBCO) (22-11-2024)
@basumallick It looks you have posted an earlier order.
Waaree Energies Ltd. – Is it just the Dawn? (22-11-2024)
the real issue is all solar cells are imported from China… what will be the impact of tariffs.
also with ongoing allegations of bidding process being compromised may cause delays in projects…
Agro Tech Foods – A small cap MNC foods FMCG (22-11-2024)
This is a very difficult business and Conagra could not make much profit… maybe merger can yield something… but still medium risk low return…
Convergent bets on some ideas – some work some dont. Camlin Fine has gone terribly wrong for them. Even Borosil Renwable was not a great investment…
India Pesticides Ltd (22-11-2024)
Yes. Management expects around 50-60cr in FY26 from Hamirpur.
Vishnu Chemicals – Is Growth sustainable? (22-11-2024)
Q2FY25 – Unexciting performance and near-term outlook, long-term story intact
• On a consolidated basis, operating revenue grew by 12% Y-o-Y to Rs. 343.8 crores in Q2 FY ’25. EBITDA degrowth of 2% to 45.1 crores, PAT degrowth of 5% to Rs.22.8 crores
• The company is facing intense competition in Chromium exports business and higher freight cost has added to the issue.
• In the Barium segment, the company saw increased volume of the Barium sulfate product and better profitability despite increase in raw material cost
• Margin was impacted due to increased raw material cost (Chrome ore and Barytes), increased shipping cost and higher fixed costs due to scheduled maintenance taken during the quarter
• While the company is expecting significant volume growth in barium segment, challenges faced in chromium segment can take couple of quarters time to subside. Hence, profit growth in H2FY25 may not be robust
• Jayansree Pharma, which was acquired by the company in current financial year, would start manufacturing Strontium carbonate from Q1FY26. It’s an import substitute product and right now there is no other player that’s producing this in India. At full operating level, considering a 10,000-ton production two years down the line, revenue could be 140 to 150 crores.
• Chrome Mining Complex acquired in Africa for backward integration, is expected to commence operations in next 6-12 months’ time (Reaching to full operating level may take two years from now). This should provide significant cost competitiveness, which in turn should also help in volume growth and better profitability in chromium segment.
• The company is planning to increase Precipitated Barium Sulfate capacity from 30000 MTPA currently to 50k to 60k MPTA in next 2 years. The company is also looking at launching another valueadded product Chromium metal during Q1FY26
Disc: Invested. I am not SEBI registered Advisor/Analyst. My view may be biased. I am not suggesting any investment action. The information provided above is for education purpose only.
Ujjivan Financial – Small Finance Bank (22-11-2024)
I don’t know. After reading up on several private sector banks, NBFCs I have come to realise that in most cases (except when there are glaring concers / irregularities such as poor business model, zero sum same – i.e. borrower has to lose for lender to win, governance issues) the issue isn’t business, the issue is people not paying heed to valuations at fundamental level and relying on other people’s work (analysts, market commentators, influencers, PMS/AIF interviews on news channel, historical valuations – history itself might be falling in bear phase) to make a judgement as to when and whether to invest.
People lose money in well run companies with excellent profitability/growth and people make money in sub-par periods of profitability. What matters is understanding economics of the business, getting confidence that the business is run by able / honest management – not one who’s behind money or status or other forms of non-shareholder-friendly motives and lastly, buy at a fair valuation with insistence on some margin of safety.
5/7/10 years down the line will a Ujjivan Small Finance Bank (or any business being evaluated) live and not just live but also thrive? And at that time will they have significantly better business economics than they do now? If the answer is yes, is the bank currently available at a valuation at which one would want to hold on to it if business economics / management remain BAU (business-as-usual)? Not prediction but based on tangible / visible economics as of now. Nobody asks these questions, some analysts do – which is helpful, but largely nobody does. Which is where I think most participants miss the forest for the trees.
Needless to say, these are just my rumblings, I could be wrong, right, whatever! But the way to think is what I am trying to highlight.
People who have been running business for decades (e.g. Ujjivan is in business since 2005 or 2007 I think) are being questioned by novices about short term business metrics like what will be this year’s return on assets and what is the current cost of funds, where will be cost to income ratio, etc. and that is being used to buy/sell the stocks and retail investors are falling prey to this. Madness!
Supriya Lifescience Ltd – pure play API (22-11-2024)
Steady EPS growth shows goods sign. Company operations to regulated market in a good sign which will help EPS growth
seems Best example for a long term wealth creation because company is doing expansion with internal accruals only no borrowings that is a great sign
also they are try to compete with Chines players. which seems a big opportunities if materials
So all the good reason for the recent run up
Dis- Invested around 280 Range and no plan for exit for next 2 to 3 years